RU-505 structure
|
Common Name | RU-505 | ||
---|---|---|---|---|
CAS Number | 1314206-29-5 | Molecular Weight | N/A | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C28H32FN5O | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of RU-505RU-505 is an effective β-amyloid (Aβ)-fibrinogen interaction inhibitor with IC50s of 5.00 and 2.72 μM in fluorescence polarization (FP) and AlphaLISA assays, respectively. RU-505 is highly permeable to the BBB. RU-505 reduces cerebral amyloid angiopathy (CAA). RU-505 can be used for the research of Alzheimer’s disease (AD)[1]. |
Name | N-Benzyl-N-[2-(dimethylamino)ethyl]-7-(4-fluorophenyl)-2-(2-methyl-2-propanyl)pyrazolo[1,5-a]pyrimidine-5-carboxamide |
---|---|
Synonym | More Synonyms |
Description | RU-505 is an effective β-amyloid (Aβ)-fibrinogen interaction inhibitor with IC50s of 5.00 and 2.72 μM in fluorescence polarization (FP) and AlphaLISA assays, respectively. RU-505 is highly permeable to the BBB. RU-505 reduces cerebral amyloid angiopathy (CAA). RU-505 can be used for the research of Alzheimer’s disease (AD)[1]. |
---|---|
Related Catalog | |
References |
Molecular Formula | C28H32FN5O |
---|
N-Benzyl-N-[2-(dimethylamino)ethyl]-7-(4-fluorophenyl)-2-(2-methyl-2-propanyl)pyrazolo[1,5-a]pyrimidine-5-carboxamide |
MFCD06620515 |
Pyrazolo[1,5-a]pyrimidine-5-carboxamide, N-[2-(dimethylamino)ethyl]-2-(1,1-dimethylethyl)-7-(4-fluorophenyl)-N-(phenylmethyl)- |
RU-505 |